Anesthesia and analgesia in oncology: what are the determinants of choice?

References

[1] Горобец Е.С., Гаряев Р.В. Рассуждения о послеоперационном обезболивании и внедрении эпидуральной анальгезии в отечественную хирургическую клинику // Регионарная анестезия и лечение острой боли. 2007. Т. 1, № 1. С. 42-51.

[2] Любошевский П.А., Забусов А.В. Влияние регионарной анестезии на метаболические и воспалительные изменения при абдоминальных операциях // Общая реаниматология. 2011. № 2. С. 31-34.

[3] Марченков Ю.В., Рябчиков М.М., Шульгин М.А. Сравнительная характеристика различных видов послеоперационной анальгезии у больных с онкологическими заболеваниями легких // Общая реаниматология. 2011. № 3. С. 32-37.

[4] Amato A., Pescatori M. Perioperative blood transfusions for the recurrence of colorectal cancer // Cochrane Database Syst. Rev. 2006; 1: CD005033.

[5] Bar-Yosef S., Melamed R., Page G. Attenuation of the tumor-promoting effect of surgery by spinal blockade in rats // Anesthesiology. 2001; 94: 1066-1073.

[6] Beilin B., Shavit Y., Hart J. Effects of anesthesia based on large versus small doses of fentanyl on natural killer cell cytotoxicity in the perioperative period // Anesth. Analg. 1996; 82: 492-497.

[7] Beilin B., Shavit Y., Razumovsky J. Effect of mild perioperative hypothermia on cellular immune responses // Anesthesiology. 1998; 89: 1133-1140.

[8] Ben-Eliahu S., Shakhar G., Rosenne E. Hypothermia in barbiturate-anesthetized rats suppresses natural killer cell activity and compromises resistance to tumor metastasis: a role for adrenergic mechanisms // Anesthesiology. 1999; 91: 732-740.

[9] Ben-Eliahu S. The promotion of tumor metastasis by surgery and stress: immunological basis and implications for psychoneuroimmunology // Brain Behav. Immun. 2003; 17 (Suppl.): 27-36.

[10] Benish M., Bartal I., Golgfarb Y. Perioperative use of betablockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis // Ann. Surg. Oncol. 2008; 15: 2042-2052.

[11] Biki B., Mascha E., Moriarty D. Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: a retrospective analysis // Anesthesiology. 2008; 109: 180-187.

[12] Brand J., Kirchner H., Poppe C. The effect of general anesthesia on human peripheral immune cell distribution and cytokine production // Clin. Immunol. Immunopathol. 1997; 83: 190-194.

[13] Bruzzone A., Pinero C., Castillo L. Alpha2 - adrenoreceptor action on cell proliferation and mammary tumor growth in mice // Br. J. Pharmacol. 2008; 155: 494-504.

[14] Chae B., Lee H., Sun K. The effect of combined epidural and light general anesthesia on stress hormones in open heart surgery patients // Surg. Today. 1998; 28: 727-731.

[15] Chen G., Zhang F., Gong M. Effect of perioperative autologuos versus allogenic blood transfusion on the immune system in gastric cancer patients // J. Zhejiang Univ. Sci. 2007; 8: 560-565.

[16] Christopherson R., James K., Tableman M. Long-term survival after colon cancer surgery: a variation associated with choice of anesthesia // Anesth. Analg. 2008; 107: 325-332.

[17] Coffey J., Wang J., Smith M. Excisional surgery for cancer cure: therapy at a cost // Lancet Oncol. 2004; 4: 760-768.

[18] Deegan S., Murray D., Doran P. Effect of anaesthetic technique on oestrogen receptor-negative breast cancer cell function in vitro // Br. J. Anaesth. 2009; 103: 685-690.

[19] Denis M., Lipart C., Leborgne J. Detection of disseminated tumor cells in peripheral bllod of colorectal cancer patients // Int. J. Cancer. 1997; 74: 540-544.

[20] Exadactylos A., Buggy D., Moriarty D. Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? // Anesthesiology. 2006; 105: 660-664.

[21] Farooqui M., Rogers T., Poonawala T. COX-2 inhibitor cele-coxib prevents chronic morphine-induced promotion of angio-genesis, tumor growth, metastasis and mortality, without compromising analgesia // Br. J. Cancer. 2007; 97: 1523-1531.

[22] Galley H., Dubbels A., Webster N. The effect of midazolam and propofol on interleukin-8 from human polymorphonuclear leucocytes // Anesth. Analg. 1998; 86: 1289-1293.

[23] Gaspani L., Bianchi M., Limiroli E. The analgesic drug tramadol prevents the effect of surgery on natural killer cell activity and metastatic colonization in rats // J. Neuroimmunol. 2002; 129: 18-24.

[24] Goldfarb Y., Ben-Eliahu S. Surgery as a risk factor for breast cancer recurrence and metastasis: mediating mechanisms and clinical prophylactic approaches // Breast. Dis. 2006; 26: 99-114.

[25] Gottschalk A., Sharma S., Ford J. The role of the perioperative period in recurrence after cancer surgery // Anesth. Analg. 2010; 110: 1636-1643.

[26] Gottschalk A., Ford J., Regelin C. Association between epidural analgesia and cancer recurrence after colorectal cancer surgery // Anesthesiology. 2010; 113: 27-34.

[27] Gupta G., Massague J. Cancer metastasis: building a framework // Cell. 2006; 127: 679-695.

[28] Gupta A., Bjornsson A., Fredriksson M. Reduction of mortality after epidural anaesthesia and analgesia in patients undergoing rectal but non colonic cancer surgery: a retrospective analysis of data from 655 patients in Central Sweden // Br. J. Anaesth. 2011; 107: 164-170.

[29] Harris R., Beebe-Donk J., Alshafie G. Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors // BMC Cancer. 2006; 6: 27.

[30] Hasegawa H., Saiki I. Psychosocial stress augments tumor development through beta-adrenergic activation in mice // Jpn. J. Cancer Res. 2002; 93: 729-735.

[31] Inada T., Ymanaoichi Y., Jomura S. Effect of propofol and isoflurane anaesthesia on the immune response to surgery // Anaesthesia. 2004; 59: 954-959.

[32] Inada T., Kubo K., Kambara T. Propofol inhibits cyclo-oxygenase activity in human monocytic THP-1 cells // Can. J. Anaesth. 2009; 56: 222-229.

[33] Jones M., Wang H., Pescar B. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing // Nat. Med. 1999; 5: 1418-1423.

[34] Ke J., Zhan J., Feng X. A comparison of the effect of total intravenous anesthesia with propofol and remifentanil and inhalation anesthesia with isoflurane on the release of pro- and anti-inflammatory cytokines in patients undergoing open cholecystectomy // Anaesth. Int. Care. 2008; 36: 74-78.

[35] Kundu J., Surh Y. Inflammation: gearing the journey to cancer // Mutat Res. 2008; 659: 15-30.

[36] Kushida A., Inada T., Shingu K. Enhancement of antitumor immunity after propofol treatment in mice // Immunopharmacol. Immunotoxicol. 2007; 29: 477-486.

[37] Leahy K., Ornberg R., Wang Y. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo // Cancer Res. 2002; 62: 625-631.

[38] Lennon F., Moss J., Singleton P.The μ-opioid receptor in cancer progression. Is there a direct effect? // Anesthesiology. 2012; 116: 940-945.

[39] Lutgendorf S., Cole S., Costanzo E. Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines // Clin. Cancer. Res. 2003; 9: 45144521.

[40] Mammoto T., Mukai M., Mammoto A. Intravenous anesthetic propofol inhibits invasion of cancer cells // Cancer Lett. 2002; 184: 165-170.

[41] Mammoto T., Higashiyama S., Mukai M. Infiltration anesthetic lidocaine inhibits cancer cell invasion by modulation ectodomain shedding of heparin-binding epidermal growth factor-like growth factor (HB-EGF) // J. Cell. Physiol. 2002; 192: 351-358.

[42] Markovic S., Knidht P., Murasko D. Inhibition of interferon stimulation of natural killer cell activity in mice anesthetized with halothane or isoflurane // Anesthesiology. 1993; 78: 700-706.

[43] Martinsson T. Ropivacaine inhibits serum-induced proliferation of colon adenocarcinoma cells in vitro // J. Pharmacol. Exp. Ther. 1999; 288: 660-664.

[44] Melamed R., Bar-Yosef S., Shakhar G. Supression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental and halothane, but not by propofol: mediating mechanisms and prophylactic measures // Anesth. Analg. 2003; 97: 1331-1339.

[45] Melamed R., Rosenne E., Shakhar K. Marginating pulmonary NK-activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a beta-adrenergic antagonist and a prostaglandin synthesis inhibitor // Brain Behav. Immun. 2005; 19: 114-126.

[46] Mitsuhata H., Shimizu R., Yokoyama M. Suppressive effects of volatile anesthetics on cytokine release in human peripheral blood mononuclear cells // Int. J. Jmmunopharmacol. 1995; 17: 529-534.

[47] Page G., Blakely W., Ben-Eliahu S. Evidence that postoperative pain is a mediator of the tumor-promoting effects of surgery in rats // Pain. 2001; 90: 191-199.

[48] Procopio M., Rassias A., DeLeo J. The in vivo effects of general and epidural anesthesia on human immune function // Anesth. Analg. 2001; 93: 460-465.

[49] Roche-Nagle G., Connolly E., Eng M. Antimetastatic activity of a cyclooxygenase-2 inhibitor // Br. J. Cancer. 2004; 91: 359-365.

[50] Sacerdote P., Bianchi M., Gaspani L. The effects of tramadol and morphine on immune responses and pain after surgery in cancer patients // Anesth. Analg. 2000; 90: 1411-1414.

[51] Sakaguchi M., Kuroda Y., Hirose M. The antiproliferative effect of lidocaine of human tongue cancer with inhibition of the activity of epidermal growth factor receptor // Anesth. Analg. 2006; 102: 1103-1107.

[52] Schlagenhauff B., Ellwanger U., Breuninger H. Prognostic impact of the type of anaesthesia used during the excision of primary cutaneous melanoma // Melanoma Res. 2000; 10: 165-169.

[53] Sessler D. Does regional analgesia reduce the risk of cancer recurrence? A hypothesis // Eur. J. Cancer Prev. 2007; 17: 269-272.

[54] Shavit Y., Ben-Eliahu S., Zeidel A. Effects of fentanil on natural killer cell activity and on resistance to tumor metastasis in rats. Dose and timing study // Neuroimmunomodulation. 2004; 11: 255-260.

[55] Smith T., Staats P., Deer T. Implantable drug delivery systems study group: randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity and survival // J. Clin. Oncol. 2002; 20: 4040-4049.

[56] Snyder G., Greenberg S. Effect of anaesthetic technique and other perioperative factors on cancer recurrence // Br. J. Anaesth. 2010; 105: 106-115.

[57] Sood A., Bhatty R., Kamat A. Stress hormone-mediated invasion of ovarian cancer cells // Clin. Cancer Res. 2006; 12: 369-375.

[58] Thaker P., Han L., Kamat A. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma // Nat. Med. 2006; 12: 939-944.

[59] Thaker P., Sood A. Neuroendocrine influences on cancer biology // Semin. Cancer Biol. 2008; 18: 164-170.

[60] Tsuchiya M., Asada A., Arita K. Induction and mechanism of apoptotic cell death by propofol in HL-60 cells // Acta An-aesth. Scand. 2002; 46: 1068-1074.

[61] Tsui B., Rashiq S., Schopflocher D. Epidural anesthesia and cancer recurrence after radical prostatectomy // Can. J. Anaesth. 2010; 57: 107-112.

[62] Wada H., Seki S., Takahashi T. Combined spinal and general anesthesia attenuates liver metastasis by preserving TH1/TH2 cytokine balance // Anesthesiology. 2007; 106: 499-506.

[63] Weber R., Jabbour N., Martin R. Anemia and transfusions in patients undergoing surgery for cancer // Ann. Surg. Oncol. 2008; 15: 34-45.

[64] Weimann J. Toxicity of nitrous oxide // Best Pract. Res. 2003; 17: 47-61.

[65] Wojtowicz-Praga S. Reversal of tumor-induced immunosupression by TGF-beta inhibitors // Invest. New Drugs. 2003; 21: 21-32.

[66] Yeager M., DeLeo J., Arruda J. Intravenous fentanil increases natural killer cel cytotoxicity and circulating CD16+ lymphocytes in humans // Anesth. Analg. 2002; 94: 94-99.

RIGHTS & PERMISSIONS

Eco-Vector